Skip to main content
Erschienen in: Endocrine 1/2015

01.02.2015 | Original Article

Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease

verfasst von: Roberto Vita, Daniela Lapa, Francesco Trimarchi, Salvatore Benvenga

Erschienen in: Endocrine | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the relationship of stressful events (SE) with the onset and outcome of Graves’ disease (GD). Over a period of 21 years, we enrolled 58 consecutive patients in whom at least one SE had occurred ≤12 months before the onset of GD. Patients were treated with antithyroid drugs (ATD) for ≥12 months and followed up for ≥5 years after ATD withdrawal. We divided patients in three groups: REM (who reached remission; 25.9 %); EXA (who experienced ≥1 exacerbation during ATD; 10.3 %); and REL (who experienced ≥1 relapse after ATD withdrawal; 63.8 %). The average age at onset was similar in the three groups. All males aged ≤25 years at GD onset relapsed at least once; no patient aged ≥51 years at GD onset relapsed ≥2 times. All patients who exacerbated or relapsed had at least one SE preceding each exacerbation or relapse. The time lag between SE and onset of GD (19.3 ± 11.9 weeks) correlated with the age at onset (r = 0.292, P = 0.0002), particularly in the REL group (r = 0.346, P = 0.001). Overall, EXA and REL patients experienced more SE than REM patients (P = 0.0002 and P = 0.003, respectively). In the REL group, the overall number of SE was correlated with the number of relapses (r = 0.486, P < 0.0001). There exist GD patients who are prone to develop hyperthyroidism and its recurrences when exposed to SE. They are relatively young; the younger these patients are, the shorter is the time lag between SE and the onset of hyperthyroidism.
Literatur
1.
Zurück zum Zitat D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)CrossRefPubMed D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)CrossRefPubMed
2.
Zurück zum Zitat F. Guarneri, S. Benvenga, Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr. Opin. Endocrinol. Diabetes Obes. 14, 398–409 (2007)CrossRefPubMed F. Guarneri, S. Benvenga, Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr. Opin. Endocrinol. Diabetes Obes. 14, 398–409 (2007)CrossRefPubMed
3.
Zurück zum Zitat T. Mizokami, A. Wu Li, S. El-Kaissi, J.R. Wall, Stress and thyroid autoimmunity. Thyroid 14, 1047–1055 (2004)CrossRefPubMed T. Mizokami, A. Wu Li, S. El-Kaissi, J.R. Wall, Stress and thyroid autoimmunity. Thyroid 14, 1047–1055 (2004)CrossRefPubMed
5.
Zurück zum Zitat L. Chiovato, M. Marinò, G. Perugi, E. Fiore, L. Montanelli, P. Lapi, R. Cavaliere, M. Ciampi, A. Patronelli, G. Placidi, G.F. Placidi, G.B. Cassano, A. Pinchera, Chronic recurrent stress due to panic disorder does not precipitate Graves’ disease. J. Endocrinol. Invest. 21, 758–764 (1998)CrossRefPubMed L. Chiovato, M. Marinò, G. Perugi, E. Fiore, L. Montanelli, P. Lapi, R. Cavaliere, M. Ciampi, A. Patronelli, G. Placidi, G.F. Placidi, G.B. Cassano, A. Pinchera, Chronic recurrent stress due to panic disorder does not precipitate Graves’ disease. J. Endocrinol. Invest. 21, 758–764 (1998)CrossRefPubMed
6.
Zurück zum Zitat G. Effraimidis, J.G. Tijssen, J.F. Brosschot, W.M. Wiersinga, Involvement of stress in the pathogenesis of autoimmune thyroid disease: a prospective study. Psychoneuroendocrinology 37, 1191–1198 (2012)CrossRefPubMed G. Effraimidis, J.G. Tijssen, J.F. Brosschot, W.M. Wiersinga, Involvement of stress in the pathogenesis of autoimmune thyroid disease: a prospective study. Psychoneuroendocrinology 37, 1191–1198 (2012)CrossRefPubMed
7.
Zurück zum Zitat C.H. Parry, Collected works. London 1, 478–480 (1825) C.H. Parry, Collected works. London 1, 478–480 (1825)
8.
Zurück zum Zitat C.A. Gorman, A critical review of the role of stress in hyperthyroidism, in The thyroid gland, environment and autoimmunity, ed. by H.A. Drexhage, J.T.M. de Vijlder, W.M. Wiersinga (Elsevier Science Publishers, Amsterdam, 1990), pp. 191–200 C.A. Gorman, A critical review of the role of stress in hyperthyroidism, in The thyroid gland, environment and autoimmunity, ed. by H.A. Drexhage, J.T.M. de Vijlder, W.M. Wiersinga (Elsevier Science Publishers, Amsterdam, 1990), pp. 191–200
9.
Zurück zum Zitat N. Paunkovic, J. Paunkovic, O. Pavlovic, Z. Paunovic, The significant increase in incidence of Graves’ disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995). Thyroid 8, 37–41 (1998)CrossRefPubMed N. Paunkovic, J. Paunkovic, O. Pavlovic, Z. Paunovic, The significant increase in incidence of Graves’ disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995). Thyroid 8, 37–41 (1998)CrossRefPubMed
10.
Zurück zum Zitat B. Winsa, A. Karlsson, R. Bergstrom, H.O. Adami, A. Gamstedt, R. Jansson, U. Adamson, P.A. Dahlberg, Stressful life events and Graves’ disease. Lancet 338, 1475–1479 (1991)CrossRefPubMed B. Winsa, A. Karlsson, R. Bergstrom, H.O. Adami, A. Gamstedt, R. Jansson, U. Adamson, P.A. Dahlberg, Stressful life events and Graves’ disease. Lancet 338, 1475–1479 (1991)CrossRefPubMed
11.
Zurück zum Zitat N. Sonino, M.E. Girelli, M. Boscaro, F. Fallo, B. Busnardo, G.A. Fava, Life events in the pathogenesis of Graves’ disease. A controlled study. Acta Endocrinol. (Copenh) 128, 293–296 (1993) N. Sonino, M.E. Girelli, M. Boscaro, F. Fallo, B. Busnardo, G.A. Fava, Life events in the pathogenesis of Graves’ disease. A controlled study. Acta Endocrinol. (Copenh) 128, 293–296 (1993)
12.
Zurück zum Zitat A.W. Kung, Life events, daily stresses and coping in patients with Graves’ disease. Clin. Endocrinol. (Oxf) 42, 303–308 (1995)CrossRef A.W. Kung, Life events, daily stresses and coping in patients with Graves’ disease. Clin. Endocrinol. (Oxf) 42, 303–308 (1995)CrossRef
13.
Zurück zum Zitat V.R. Radosavljević, S.M. Janković, J.M. Marinković, Stressful life events in the pathogenesis of Graves’ disease. Eur. J. Endocrinol. 134, 699–701 (1996)CrossRefPubMed V.R. Radosavljević, S.M. Janković, J.M. Marinković, Stressful life events in the pathogenesis of Graves’ disease. Eur. J. Endocrinol. 134, 699–701 (1996)CrossRefPubMed
14.
Zurück zum Zitat K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, Y. Ohashi, T. Kuboki, H. Suematsu, Stressful life events and smoking were associated with Graves’ disease in women, but not in men. Psychosom. Med. 60, 182–185 (1998)CrossRefPubMed K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, Y. Ohashi, T. Kuboki, H. Suematsu, Stressful life events and smoking were associated with Graves’ disease in women, but not in men. Psychosom. Med. 60, 182–185 (1998)CrossRefPubMed
15.
Zurück zum Zitat R.C. Martin-du Pan, Triggering role of emotional stress and childbirth. Unexpected occurrence of Graves’ disease compared to 96 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules. Ann. Endocrinol. (Paris) 59, 107–112 (1998) R.C. Martin-du Pan, Triggering role of emotional stress and childbirth. Unexpected occurrence of Graves’ disease compared to 96 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules. Ann. Endocrinol. (Paris) 59, 107–112 (1998)
16.
Zurück zum Zitat A. Matos-Santos, E.L. Nobre, J.G.E. Costa, P.J. Nogueira, A. Macedo, A. Galvão-Teles, J.J. De Castro, Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goitre. Clin. Endocrinol. (Oxf) 55, 15–19 (2001)CrossRef A. Matos-Santos, E.L. Nobre, J.G.E. Costa, P.J. Nogueira, A. Macedo, A. Galvão-Teles, J.J. De Castro, Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goitre. Clin. Endocrinol. (Oxf) 55, 15–19 (2001)CrossRef
17.
Zurück zum Zitat M. Bagnasco, I. Bossert, G. Pesce, Stress and autoimmune thyroid diseases. NeuroImmunoModulation 13, 309–317 (2006)CrossRefPubMed M. Bagnasco, I. Bossert, G. Pesce, Stress and autoimmune thyroid diseases. NeuroImmunoModulation 13, 309–317 (2006)CrossRefPubMed
18.
Zurück zum Zitat C.B. Topcu, O. Celik, E. Tasan, Effect of stressful life events on the initiation of Graves’ disease. Int. J. Psychiatry Clin. Pract. 16, 307–311 (2012)CrossRefPubMed C.B. Topcu, O. Celik, E. Tasan, Effect of stressful life events on the initiation of Graves’ disease. Int. J. Psychiatry Clin. Pract. 16, 307–311 (2012)CrossRefPubMed
19.
Zurück zum Zitat X.G. Vos, N. Smit, E. Endert, J.F. Brosschot, J.G.P. Tijssen, W.M. Wiersinga, Age and stress as determinants of the severity of hyperthyroidism caused by Graves’ disease in newly diagnosed patients. Eur. J. Endocrinol. 160, 193–199 (2009)CrossRefPubMed X.G. Vos, N. Smit, E. Endert, J.F. Brosschot, J.G.P. Tijssen, W.M. Wiersinga, Age and stress as determinants of the severity of hyperthyroidism caused by Graves’ disease in newly diagnosed patients. Eur. J. Endocrinol. 160, 193–199 (2009)CrossRefPubMed
20.
Zurück zum Zitat T.G. Strieder, M.F. Prummel, J.G. Tijssen, J.F. Brosschot, W.M. Wiersinga, Stress is not associated with thyroid peroxidase autoantibodies in euthyroid women. Brain Behav. Immun. 19, 203–206 (2005)CrossRefPubMed T.G. Strieder, M.F. Prummel, J.G. Tijssen, J.F. Brosschot, W.M. Wiersinga, Stress is not associated with thyroid peroxidase autoantibodies in euthyroid women. Brain Behav. Immun. 19, 203–206 (2005)CrossRefPubMed
21.
Zurück zum Zitat G. Effraimidis, T.G. Strieder, J.G. Tijssen, W.M. Wiersinga, Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur. J. Endocrinol. 164, 107–113 (2011)CrossRefPubMed G. Effraimidis, T.G. Strieder, J.G. Tijssen, W.M. Wiersinga, Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur. J. Endocrinol. 164, 107–113 (2011)CrossRefPubMed
22.
Zurück zum Zitat K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, T. Kuboki, H. Suematsu, Psychosocial factors influencing the short-term outcome of antithyroid drug therapy in Graves’ disease. Psychosom. Med. 60, 592–596 (1998)CrossRefPubMed K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, T. Kuboki, H. Suematsu, Psychosocial factors influencing the short-term outcome of antithyroid drug therapy in Graves’ disease. Psychosom. Med. 60, 592–596 (1998)CrossRefPubMed
23.
Zurück zum Zitat T. Stewart, J. Rochon, R. Lenfestey, P. Wise, Correlation of stress with outcome of radioiodine therapy for Graves’ disease. J. Nucl. Med. 26, 592–599 (1985)PubMed T. Stewart, J. Rochon, R. Lenfestey, P. Wise, Correlation of stress with outcome of radioiodine therapy for Graves’ disease. J. Nucl. Med. 26, 592–599 (1985)PubMed
24.
25.
Zurück zum Zitat R. Vita, D. Lapa, G. Vita, F. Trimarchi, S. Benvenga, A patient with stress-related onset and exacerbations of Graves’ disease. Nat. Clin. Pract. Endocrinol. Metab. 5, 55–61 (2009)CrossRefPubMed R. Vita, D. Lapa, G. Vita, F. Trimarchi, S. Benvenga, A patient with stress-related onset and exacerbations of Graves’ disease. Nat. Clin. Pract. Endocrinol. Metab. 5, 55–61 (2009)CrossRefPubMed
26.
Zurück zum Zitat G. Falgarone, H.M. Heshmati, R. Cohen, G. Reach, Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves’ disease. Eur. J. Endocrinol. 168, R13–R18 (2012)CrossRefPubMed G. Falgarone, H.M. Heshmati, R. Cohen, G. Reach, Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves’ disease. Eur. J. Endocrinol. 168, R13–R18 (2012)CrossRefPubMed
27.
Zurück zum Zitat A. Tsatsoulis, The role of stress in the clinical expression of thyroid autoimmunity. Ann. N. Y. Acad. Sci. 1088, 382–395 (2006)CrossRefPubMed A. Tsatsoulis, The role of stress in the clinical expression of thyroid autoimmunity. Ann. N. Y. Acad. Sci. 1088, 382–395 (2006)CrossRefPubMed
28.
Zurück zum Zitat T. Nanba, M. Watanabe, N. Inoue, Y. Iwatani, Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid 19, 495–501 (2009)CrossRefPubMed T. Nanba, M. Watanabe, N. Inoue, Y. Iwatani, Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid 19, 495–501 (2009)CrossRefPubMed
29.
Zurück zum Zitat C. Mao, S. Wang, Y. Xiao, J. Xu, Q. Jiang, M. Jin, X. Jiang, H. Guo, G. Ning, Y. Zhang, Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J. Immunol. 186, 4734–4743 (2011)CrossRefPubMed C. Mao, S. Wang, Y. Xiao, J. Xu, Q. Jiang, M. Jin, X. Jiang, H. Guo, G. Ning, Y. Zhang, Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J. Immunol. 186, 4734–4743 (2011)CrossRefPubMed
30.
Zurück zum Zitat A.P. Weetman, Immunity, thyroid function and pregnancy: molecular mechanisms. Nat. Rev. Endocrinol. 6, 311–318 (2010)CrossRefPubMed A.P. Weetman, Immunity, thyroid function and pregnancy: molecular mechanisms. Nat. Rev. Endocrinol. 6, 311–318 (2010)CrossRefPubMed
31.
Zurück zum Zitat M. Rotondi, C. Cappelli, B. Pirali, I. Pirola, F. Magri, R. Fonte, M. Castellano, E.A. Rosei, L. Chiovato, The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J. Clin. Endocrinol. Metab. 93, 3985–3988 (2008)CrossRefPubMed M. Rotondi, C. Cappelli, B. Pirali, I. Pirola, F. Magri, R. Fonte, M. Castellano, E.A. Rosei, L. Chiovato, The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J. Clin. Endocrinol. Metab. 93, 3985–3988 (2008)CrossRefPubMed
32.
Zurück zum Zitat J.K. Kiecolt-Glaser, K.J. Preacher, R.C. MacCallum, C. Atkinson, W.B. Malarkey, R. Glaser, Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100, 9090–9095 (2003)CrossRefPubMedCentralPubMed J.K. Kiecolt-Glaser, K.J. Preacher, R.C. MacCallum, C. Atkinson, W.B. Malarkey, R. Glaser, Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100, 9090–9095 (2003)CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat K. Agbaht, S. Gullu, Adrenocortical reserves in hyperthyroidism. Endocrine 45, 136–143 (2014)CrossRefPubMed K. Agbaht, S. Gullu, Adrenocortical reserves in hyperthyroidism. Endocrine 45, 136–143 (2014)CrossRefPubMed
34.
Zurück zum Zitat M.E. Forteza, Precipitating factors in hyperthyroidism. Geriatrics 28, 123–126 (1973)PubMed M.E. Forteza, Precipitating factors in hyperthyroidism. Geriatrics 28, 123–126 (1973)PubMed
35.
Zurück zum Zitat P. Vitti, T. Rago, L. Chiovato, S. Pallini, F. Santini, E. Fiore, R. Rocchi, E. Martino, A. Pinchera, Clinical features of patients with Graves’ disease undergoing remission after antithyroid drug treatment. Thyroid 7, 369–375 (1997)CrossRefPubMed P. Vitti, T. Rago, L. Chiovato, S. Pallini, F. Santini, E. Fiore, R. Rocchi, E. Martino, A. Pinchera, Clinical features of patients with Graves’ disease undergoing remission after antithyroid drug treatment. Thyroid 7, 369–375 (1997)CrossRefPubMed
36.
Zurück zum Zitat A. Allahabadia, J. Daykin, R.L. Holder, M.C. Sheppard, S.C. Gough, J.A. Franklyn, Age and gender predict the outcome of treatment for Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 85, 1038–1042 (2000)PubMed A. Allahabadia, J. Daykin, R.L. Holder, M.C. Sheppard, S.C. Gough, J.A. Franklyn, Age and gender predict the outcome of treatment for Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 85, 1038–1042 (2000)PubMed
37.
Zurück zum Zitat A. Fukao, J. Takamatsu, Y. Murakami, S. Sakane, A. Miyauchi, K. Kuma, S. Hayashi, T. Hanafusa, The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves’ disease. Clin. Endocrinol. (Oxf) 58, 550–555 (2003)CrossRef A. Fukao, J. Takamatsu, Y. Murakami, S. Sakane, A. Miyauchi, K. Kuma, S. Hayashi, T. Hanafusa, The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves’ disease. Clin. Endocrinol. (Oxf) 58, 550–555 (2003)CrossRef
38.
Zurück zum Zitat T. Lidz, Emotional factors in the etiology of hyperthyroidism. Psychosom. Med. 11, 2–8 (1949)CrossRefPubMed T. Lidz, Emotional factors in the etiology of hyperthyroidism. Psychosom. Med. 11, 2–8 (1949)CrossRefPubMed
39.
Zurück zum Zitat E. Morillo, L.I. Gardner, Bereavement as an antecedent factor in thyrotoxicosis of childhood: four case studies with survey of possible metabolic pathways. Psychosom. Med. 41, 545–555 (1979)CrossRefPubMed E. Morillo, L.I. Gardner, Bereavement as an antecedent factor in thyrotoxicosis of childhood: four case studies with survey of possible metabolic pathways. Psychosom. Med. 41, 545–555 (1979)CrossRefPubMed
40.
Zurück zum Zitat S.M. Ferguson-Rayport, The relation of emotional stress factors to recurrence of thyrotoxicosis. Can. Med. Assoc. J. 75, 993–1000 (1956)PubMedCentralPubMed S.M. Ferguson-Rayport, The relation of emotional stress factors to recurrence of thyrotoxicosis. Can. Med. Assoc. J. 75, 993–1000 (1956)PubMedCentralPubMed
41.
Zurück zum Zitat Y. Hidaka, M.N. Amino, E. Iwatani, E. Itoh, M. Matsunaga, H. Tamaki, Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 77, 1667–1670 (1993)PubMed Y. Hidaka, M.N. Amino, E. Iwatani, E. Itoh, M. Matsunaga, H. Tamaki, Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 77, 1667–1670 (1993)PubMed
42.
Zurück zum Zitat K. Kamoi, M. Tanaka, T. Ikarashi, M. Miyakoshi, Effect of the 2004 mid Niigata prefecture earthquake on patients with endocrine disorders. Endocr. J. 53, 511–521 (2006)CrossRefPubMed K. Kamoi, M. Tanaka, T. Ikarashi, M. Miyakoshi, Effect of the 2004 mid Niigata prefecture earthquake on patients with endocrine disorders. Endocr. J. 53, 511–521 (2006)CrossRefPubMed
Metadaten
Titel
Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease
verfasst von
Roberto Vita
Daniela Lapa
Francesco Trimarchi
Salvatore Benvenga
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0289-8

Weitere Artikel der Ausgabe 1/2015

Endocrine 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.